Story perspectives

FDA Approves Generic Mifepristone Amid Legal Challenges and Misinformation

10/27/2025

50 3

Center

FDA Approves Mifepristone

The U.S. Food and Drug Administration approved a second generic form of mifepristone.
Antiabortion groups are pressing U.S. President Donald Trump for stricter regulations after the approval.
Clinics in Wisconsin have suspended services due to funding cuts.
Louisiana's Attorney General is pursuing legal challenges against out-of-state providers.
Experts warn that misinformation and legal actions could further restrict access to mifepristone even as it remains available for now.

Left

Newsom Protects Abortion

AB 260, signed by Governor Gavin Newsom on October 3, 2025, authorizes confidential dispensing of mifepristone and omits patient and prescriber names.
The law aims to shield providers and patients from criminal investigations and civil lawsuits in states with abortion bans.
It also requires coverage for mifepristone regardless of FDA approval changes and strengthens protections against legal retaliation, serving as a model for other pro-choice states.

1 of 2

FDA Approves Mifepristone

The U.S. Food and Drug Administration approved a second generic form of mifepristone.
Antiabortion groups are pressing U.S. President Donald Trump for stricter regulations after the approval.
Clinics in Wisconsin have suspended services due to funding cuts.
Louisiana's Attorney General is pursuing legal challenges against out-of-state providers.
Experts warn that misinformation and legal actions could further restrict access to mifepristone even as it remains available for now.

1 / 2